Contributors

Abdelnour, Carla; Abela, Angela; Arnaldi, Dario; Au, Rhoda; Balma, Michele; Barbarino, Paola; Barbera, Mariagnese; Bauckneht, Matteo; Bilbo, Staci D.; Biskup, Ewelina; Campbell, Stephen; Chadha, Antonella Santuccione; Chincarini, A.; Delage, Charlotte; Dimech, Annemarie Schumacher; Diviani, Nicola; Downie, Sue; Esteban, Ester; Ferraro, Pilar M.; Ferretti, Maria Teresa; Foldi, Nancy S.; Galea, Liisa A.M.; Gammada, Emnet; Grazzini, Matteo; Håkansson, Krister; Hill-Strathy, MaryJane; Ilinca, Stefania; Ippati, Stefania; Ittner, Lars M.; Jordan, Valeria; Ke, Yazi D.; Kivipelto, Miia; Lapucci, Caterina; Lee, Bonnie H.; Lehtisalo, Jenni; Lorenz-Dant, Klara; Lynch, Christopher S.; Malacon, Karen; Martínková, J; Massa, Federico; Meli, Riccardo; Mellino, Simona; Mielke, Michelle M.; Mittelman, Mary; Morbelli, Silvia; Nasta, Beatrice; Nobili, Flavio; Pardini, Matteo; Peira, Enrico; Phillips, Susan D.; Puri, Tanvi; Raffa, Stefano; Rauen, Katrin; Rendina, Danielle N.; Roccatagliata, Luca; Rosenberg, Anna; Rosende-Roca, Maiteé; Rovira, M.; Rubinelli, Sara; Scerri, Anthony; Scerri, Charles; Sindi, Shireen; Stephen, Ruth; Suzuki, Elina; Szoeke, Cassandra; Toopchiani, Sima; Tremblay, Marie‐Ève; Udeh-Momoh, Chinedu; Weidner, Wendy

doi:10.1016/b978-0-12-819344-0.09984-1

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several differences in clinical phenotypes have been described among men and women living with AD. We have summarized such differences in several reviews ( Ferretti et al, 2018 , 2020 ; Martinkova et al, 2021 ), a dedicated special issue ( Mielke et al, 2018 ), as well as in the different textbooks on the topic ( Abdelnour et al, 2021 ; Moro et al, 2022 ). In sum, the body of data suggests that sex is an essential component in the phenotypic heterogeneity of AD and should not be overlooked in clinical practice or preclinical research.…”

Section: Sex and Gender Differences And Clinical Outcomes In Alzheime...mentioning

confidence: 99%

Sex and gender considerations in Alzheimer’s disease: The Women’s Brain Project contribution

Castro-Aldrete

Moser

Putignano

et al. 2023

Front. Aging Neurosci.

Self Cite

View full text Add to dashboard Cite

The global population is expected to have about 131.5 million people living with Alzheimer’s disease (AD) and other dementias by 2050, posing a severe health crisis. Dementia is a progressive neurodegenerative condition that gradually impairs physical and cognitive functions. Dementia has a variety of causes, symptoms, and heterogeneity concerning the influence of sex on prevalence, risk factors, and outcomes. The proportion of male-to-female prevalence varies based on the type of dementia. Despite some types of dementia being more common in men, women have a greater lifetime risk of developing dementia. AD is the most common form of dementia in which approximately two-thirds of the affected persons are women. Profound sex and gender differences in physiology and pharmacokinetic and pharmacodynamic interactions have increasingly been identified. As a result, new approaches to dementia diagnosis, care, and patient journeys should be considered. In the heart of a rapidly aging worldwide population, the Women’s Brain Project (WBP) was born from the necessity to address the sex and gender gap in AD. WBP is now a well-established international non-profit organization with a global multidisciplinary team of experts studying sex and gender determinants in the brain and mental health. WBP works with different stakeholders worldwide to help change perceptions and reduce sex biases in clinical and preclinical research and policy frameworks. With its strong female leadership, WBP is an example of the importance of female professionals’ work in the field of dementia research. WBP-led peer-reviewed papers, articles, books, lectures, and various initiatives in the policy and advocacy space have profoundly impacted the community and driven global discussion. WBP is now in the initial phases of establishing the world’s first Sex and Gender Precision Medicine Institute. This review highlights the contributions of the WBP team to the field of AD. This review aims to increase awareness of potentially important aspects of basic science, clinical outcomes, digital health, policy framework and provide the research community with potential challenges and research suggestions to leverage sex and gender differences. Finally, at the end of the review, we briefly touch upon our progress and contribution toward sex and gender inclusion beyond Alzheimer’s disease.

show abstract